Pharmacologicinhibition of Akt using LY294002 and Akt1/2 knockdown using shRNA in sarcoma CSCsdecreased Nanog expression and spheroid formation and reversed chemotherapyresistance. This evidence concerns the gene AKT1 and sarcoma.